GI Gold: Essential Gastroenterology Concepts for Your FNP Boards
Gastroenterology · 7 min read · July 6, 2026
GI Gold: Essential Gastroenterology Concepts for Your FNP Boards
Hey future FNPs! Gastroenterology can feel like a vast and complex system, but for your board exams, you need to focus on the high-yield conditions and their management. Dr. Debesa and I are here to help you cut through the noise and zero in on what truly matters. Let's dive into the core GI concepts that will build your confidence and earn you those crucial points on exam day.
Unpacking Upper GI Disorders: GERD and PUD
When it comes to the upper GI tract, Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD) are two heavy hitters you absolutely must know. They often present with similar symptoms, but their underlying causes and management strategies differ significantly.
Gastroesophageal Reflux Disease (GERD)
GERD is a chronic condition where stomach acid or bile flows back into the esophagus, causing irritation. The hallmark symptom is heartburn, often worse after meals, when lying down, or bending over. Other symptoms can include regurgitation, dysphagia (difficulty swallowing), chronic cough, or hoarseness.
Key Pathophysiology: The primary culprit is a weakened or relaxed lower esophageal sphincter (LES), allowing reflux. Obesity, pregnancy, certain foods (caffeine, alcohol, fatty foods), and medications can exacerbate it.
Diagnosis: Often clinical, based on symptoms. An endoscopy might be performed if alarm symptoms are present (e.g., dysphagia, odynophagia, weight loss, GI bleeding, anemia) or if symptoms are refractory to treatment. 24-hour pH monitoring is the gold standard but rarely needed for initial diagnosis.
Management:
- Lifestyle Modifications: Elevating the head of the bed, avoiding trigger foods, eating smaller meals, not eating 2-3 hours before bed, weight loss, and smoking cessation.
- Pharmacology:
- Antacids: For immediate, temporary relief.
- H2 Receptor Blockers (H2RAs): e.g., famotidine (Pepcid), ranitidine (Zantac - now largely off the market due to NDMA contamination concerns). Provide longer relief than antacids.
- Proton Pump Inhibitors (PPIs): e.g., omeprazole (Prilosec), pantoprazole (Protonix). The most effective for healing esophagitis and controlling symptoms. Typically prescribed for 8 weeks, then re-evaluated. Long-term use has potential risks (e.g., C. difficile infection, osteoporosis, kidney disease).
Clinical Pearl: Remember that Barrett's Esophagus is a serious complication of chronic GERD, involving metaplastic changes in the esophageal lining, increasing the risk of esophageal adenocarcinoma. Patients with long-standing GERD, especially with alarm symptoms, need endoscopy for screening.
Peptic Ulcer Disease (PUD)
PUD involves open sores that develop on the inside lining of your stomach (gastric ulcers) and the upper part of your small intestine (duodenal ulcers). The two main causes are Helicobacter pylori (H. pylori) infection and NSAID use.
Symptoms: The most common symptom is epigastric pain, often described as burning or gnawing.
- Duodenal ulcers: Pain typically improves with food and recurs 2-3 hours after eating, often waking the patient at night.
- Gastric ulcers: Pain often worsens with food.
Diagnosis: Endoscopy with biopsy is the gold standard, allowing for direct visualization and H. pylori testing. Non-invasive H. pylori tests include urea breath test, stool antigen test, and serology (though serology only indicates exposure, not active infection).
Management:
- H. pylori Eradication: Triple or quadruple therapy (e.g., PPI + two antibiotics like amoxicillin and clarithromycin, sometimes with metronidazole or bismuth). Always confirm eradication 4-6 weeks after treatment with a urea breath test or stool antigen test.
- NSAID-induced ulcers: Discontinue NSAIDs if possible. Treat with a PPI for 8 weeks. Consider prophylactic PPIs for patients who must continue NSAIDs and are at high risk.
- Lifestyle: Avoid smoking, alcohol, and stress.
Board Tip: When differentiating GERD and PUD on the boards, pay close attention to the timing of pain relative to meals and the presence of alarm symptoms which point towards a need for endoscopy.
Navigating Lower GI: Diverticulitis and Irritable Bowel Syndrome (IBS)
Moving to the lower GI tract, diverticulitis and IBS are common conditions with distinct presentations and management.
Diverticulitis
Diverticulosis is the presence of small, bulging pouches (diverticula) in the colon wall, common in older adults. Diverticulitis occurs when these pouches become inflamed or infected.
Symptoms: The classic presentation is left lower quadrant (LLQ) abdominal pain, often sudden in onset, accompanied by fever, nausea, vomiting, and changes in bowel habits (constipation or diarrhea). A palpable mass may be present.
Diagnosis: CT scan of the abdomen and pelvis with oral and IV contrast is the diagnostic test of choice. It confirms inflammation and can rule out complications like abscess or perforation. Avoid colonoscopy during acute diverticulitis due to perforation risk; it's typically done 6-8 weeks after resolution to rule out malignancy.
Management:
- Uncomplicated Diverticulitis (outpatient): Oral antibiotics (e.g., ciprofloxacin + metronidazole or amoxicillin/clavulanate), clear liquid diet, pain control. Advance diet as tolerated.
- Complicated Diverticulitis (inpatient): IV antibiotics, NPO, IV fluids. May require surgical consultation.
Clinical Pearl: For acute diverticulitis, remember the LLQ pain and the CT scan as the key diagnostic tool. High fiber diet is for preventing diverticulitis, not for acute treatment.
Irritable Bowel Syndrome (IBS)
IBS is a common functional GI disorder characterized by chronic abdominal pain and altered bowel habits (constipation, diarrhea, or mixed) without any identifiable organic cause.
Diagnosis: Based on the Rome IV criteria: Recurrent abdominal pain, on average, at least one day per week in the last three months, associated with two or more of the following:
- Related to defecation.
- Associated with a change in frequency of stool.
- Associated with a change in form (appearance) of stool.
Important: IBS is a diagnosis of exclusion. Always rule out other conditions, especially if alarm symptoms are present (e.g., weight loss, nocturnal diarrhea, GI bleeding, anemia, family history of IBD or colon cancer).
Management: Highly individualized and focuses on symptom management.
- Dietary Modifications: FODMAP diet (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) can be very effective. Identifying trigger foods.
- Pharmacology:
- IBS-C (constipation-predominant): Fiber supplements, osmotic laxatives (polyethylene glycol), lubiprostone, linaclotide.
- IBS-D (diarrhea-predominant): Loperamide, rifaximin, alosetron (with strict risk management due to side effects).
- Abdominal Pain: Antispasmodics (dicyclomine), low-dose tricyclic antidepressants (TCAs) or SSRIs.
- Lifestyle: Stress management, regular exercise.
Board Tip: The key to diagnosing IBS on the boards is recognizing the chronic abdominal pain with altered bowel habits in the absence of alarm symptoms and a normal physical exam/basic labs. It's a functional disorder, not structural.
Hepatitis: A Quick Board Review
Hepatitis, inflammation of the liver, is crucial for your boards, particularly Hepatitis B and C due to their chronic nature and public health implications.
Hepatitis B (HBV)
Transmitted via blood and body fluids. Can be acute or chronic. Chronic HBV can lead to cirrhosis, liver failure, and hepatocellular carcinoma.
Key Serology Markers:
- HBsAg (Hepatitis B surface antigen): Indicates active infection (acute or chronic). If positive for >6 months, it's chronic.
- Anti-HBs (Hepatitis B surface antibody): Indicates immunity (from vaccination or past infection).
- Anti-HBc (Hepatitis B core antibody): Indicates past or present infection. IgM anti-HBc indicates acute infection.
- HBeAg (Hepatitis B e-antigen): Indicates active viral replication and high infectivity.
Management: Acute HBV is usually supportive. Chronic HBV requires antiviral therapy and monitoring by a specialist.
Board Tip: Understand the serology panel for HBV cold. Be able to interpret which markers indicate acute infection, chronic infection, immunity from vaccination, or immunity from past infection. This is a very common board question format.
Hepatitis C (HCV)
Transmitted primarily via blood (e.g., IV drug use, contaminated blood products before 1992). Most acute infections become chronic (75-85%). Chronic HCV is a leading cause of cirrhosis and liver transplantation.
Diagnosis:
- Anti-HCV (Hepatitis C antibody): Initial screening test. If positive, proceed to HCV RNA.
- HCV RNA (viral load): Confirms active infection.
Management: Direct-acting antiviral (DAA) medications have revolutionized HCV treatment, achieving high cure rates. Treatment is typically managed by a specialist.
Feeling Confident Yet?
Mastering these core gastroenterology concepts will significantly boost your performance on the FNP boards. Remember, it's not about memorizing every single detail, but understanding the key diagnostic criteria, management principles, and clinical pearls for the most common conditions. You've got this! Keep practicing, keep reviewing, and trust in your preparation.
Ready to solidify your knowledge and ace your FNP boards? Explore our comprehensive board prep resources, including Q-banks and review courses, designed to help you succeed.
Conquer Your GI Questions
Comprehensive FNP board prep resources at your fingertips.